采用小鼠模型研究具有流行意义的结核分枝杆菌基因型的毒力并评价化疗的有效性

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES International Journal of Infectious Diseases Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI:10.1016/j.ijid.2024.107416
Dr Igor Mokrousov , Prof. Tatiana Vinogradova , Dr. Marine Dogonadze , Dr. Natalia Zabolotnykh , Dr. Marina Dyakova , Dr. Dilyara Esmedlyaeva , Dr. Maria Vitovskaya , Dr Olga Rubtsova , Dr Sergei Chekrygin , Dr Anna Vyazovaya , Prof. Boris Ariel
{"title":"采用小鼠模型研究具有流行意义的结核分枝杆菌基因型的毒力并评价化疗的有效性","authors":"Dr Igor Mokrousov ,&nbsp;Prof. Tatiana Vinogradova ,&nbsp;Dr. Marine Dogonadze ,&nbsp;Dr. Natalia Zabolotnykh ,&nbsp;Dr. Marina Dyakova ,&nbsp;Dr. Dilyara Esmedlyaeva ,&nbsp;Dr. Maria Vitovskaya ,&nbsp;Dr Olga Rubtsova ,&nbsp;Dr Sergei Chekrygin ,&nbsp;Dr Anna Vyazovaya ,&nbsp;Prof. Boris Ariel","doi":"10.1016/j.ijid.2024.107416","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The clinical manifestations of tuberculosis (TB) in humans represent a complex interaction between the causative agent, Mycobacterium tuberculosis, and the immune response of the human host. Using the murine model, we compared virulence of M. tuberculosis strains of the medically significant genotypes and evaluated the effectiveness of anti-TB therapy and inflammatory response in infected mice.</div></div><div><h3>Methods</h3><div>The C57BL/6 mice were infected with multidrug-resistant clinical M. tuberculosis strains of Beijing and LAM genotypes. Control groups were not treated and experimental groups received adequate treatment with moxifloxacin, linezolid, bedaquiline and perchlozone. After 2 and 5.5 months of therapy, groups of mice were euthanized and studied for bacterial load, histology, lung pathology, and biochemical markers of liver damage. Whole genome sequencing was performed on all bacterial isolates from the lungs of the treated mice and the obtained fastq files were analyzed using SAM-TB tool and Geneious package. This study was funded by Russian Science Foundation (grant 24-44-00004).</div></div><div><h3>Results</h3><div>The anti-TB therapy reduced the inflammation and tuberculous lung damage in all groups of mice, even in those infected with the most virulent strain Beijing 396. A significant effect of the anti-TB therapy was observed at both time-point for all groups. The highest effectiveness of the therapy was observed in mice infected with the least virulent strains Beijing 6691 and LAM 7074. At the same time, in 3 out of 4 groups of treated mice (except for those infected with the low-virulent strain LAM 7074), a slight increase in bacterial load was recorded by the end of the 5.5-month course of therapy. High-coverage WGS analysis showed that no mutations associated with resistance to the administered drugs emerged after 5.5 months of treatment. The study of non-specific inflammatory response revealed the differently severe acute inflammation in mice infected with different strains.</div></div><div><h3>Discussion</h3><div>The highest lung damage was observed in treated mice infected with Beijing 396, the lowest – in mice infected with low-virulent Beijing 6691 and LAM 7074. At the same time, the contrasting inflammatory responses were observed in mice infected with the LAM strains: the highest in those infected by highly-virulent strain 4542 (SIT266), the lowest – in mice infected with low-virulent strain 7074 (SIT252). Phylogenetically, these LAM strains belong to the genetically homogeneous LAM-RUS branch and their contrasting in vivo manifestation is noteworthy.</div></div><div><h3>Conclusions</h3><div>Some of the observed differences between studied strains distinguish between low-virulent and highly-virulent strains irrespective of the genotype. On the other hand, some other features were common for the strains of the same genotype either Beijing or LAM and might correlate with deeply rooted lineage-specific evolutionary changes in genomes. Overall, our results emphasize the diversity of ways in which M. tuberculosis strains of different genotypes adapt to the host.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"152 ","pages":"Article 107416"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of murine model to study virulence of epidemically significant Mycobacterium tuberculosis genotypes and to evaluate effectiveness of chemotherapy\",\"authors\":\"Dr Igor Mokrousov ,&nbsp;Prof. Tatiana Vinogradova ,&nbsp;Dr. Marine Dogonadze ,&nbsp;Dr. Natalia Zabolotnykh ,&nbsp;Dr. Marina Dyakova ,&nbsp;Dr. Dilyara Esmedlyaeva ,&nbsp;Dr. Maria Vitovskaya ,&nbsp;Dr Olga Rubtsova ,&nbsp;Dr Sergei Chekrygin ,&nbsp;Dr Anna Vyazovaya ,&nbsp;Prof. Boris Ariel\",\"doi\":\"10.1016/j.ijid.2024.107416\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The clinical manifestations of tuberculosis (TB) in humans represent a complex interaction between the causative agent, Mycobacterium tuberculosis, and the immune response of the human host. Using the murine model, we compared virulence of M. tuberculosis strains of the medically significant genotypes and evaluated the effectiveness of anti-TB therapy and inflammatory response in infected mice.</div></div><div><h3>Methods</h3><div>The C57BL/6 mice were infected with multidrug-resistant clinical M. tuberculosis strains of Beijing and LAM genotypes. Control groups were not treated and experimental groups received adequate treatment with moxifloxacin, linezolid, bedaquiline and perchlozone. After 2 and 5.5 months of therapy, groups of mice were euthanized and studied for bacterial load, histology, lung pathology, and biochemical markers of liver damage. Whole genome sequencing was performed on all bacterial isolates from the lungs of the treated mice and the obtained fastq files were analyzed using SAM-TB tool and Geneious package. This study was funded by Russian Science Foundation (grant 24-44-00004).</div></div><div><h3>Results</h3><div>The anti-TB therapy reduced the inflammation and tuberculous lung damage in all groups of mice, even in those infected with the most virulent strain Beijing 396. A significant effect of the anti-TB therapy was observed at both time-point for all groups. The highest effectiveness of the therapy was observed in mice infected with the least virulent strains Beijing 6691 and LAM 7074. At the same time, in 3 out of 4 groups of treated mice (except for those infected with the low-virulent strain LAM 7074), a slight increase in bacterial load was recorded by the end of the 5.5-month course of therapy. High-coverage WGS analysis showed that no mutations associated with resistance to the administered drugs emerged after 5.5 months of treatment. The study of non-specific inflammatory response revealed the differently severe acute inflammation in mice infected with different strains.</div></div><div><h3>Discussion</h3><div>The highest lung damage was observed in treated mice infected with Beijing 396, the lowest – in mice infected with low-virulent Beijing 6691 and LAM 7074. At the same time, the contrasting inflammatory responses were observed in mice infected with the LAM strains: the highest in those infected by highly-virulent strain 4542 (SIT266), the lowest – in mice infected with low-virulent strain 7074 (SIT252). Phylogenetically, these LAM strains belong to the genetically homogeneous LAM-RUS branch and their contrasting in vivo manifestation is noteworthy.</div></div><div><h3>Conclusions</h3><div>Some of the observed differences between studied strains distinguish between low-virulent and highly-virulent strains irrespective of the genotype. On the other hand, some other features were common for the strains of the same genotype either Beijing or LAM and might correlate with deeply rooted lineage-specific evolutionary changes in genomes. Overall, our results emphasize the diversity of ways in which M. tuberculosis strains of different genotypes adapt to the host.</div></div>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":\"152 \",\"pages\":\"Article 107416\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1201971224004910\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971224004910","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

人类结核病(TB)的临床表现是病原体结核分枝杆菌和人类宿主免疫反应之间复杂的相互作用。通过小鼠模型,我们比较了医学上重要的基因型结核分枝杆菌菌株的毒力,并评估了抗结核治疗的有效性和感染小鼠的炎症反应。方法采用北京基因型和LAM基因型临床多重耐药结核分枝杆菌感染C57BL/6小鼠。对照组不予治疗,实验组给予莫西沙星、利奈唑胺、贝达喹啉、过氯酮等适当治疗。治疗2个月和5.5个月后,对各组小鼠实施安乐死,研究细菌负荷、组织学、肺部病理和肝损伤的生化指标。对治疗小鼠肺部分离的所有细菌进行全基因组测序,并使用SAM-TB工具和genous软件包对获得的fastq文件进行分析。本研究由俄罗斯科学基金会资助(批准号24-44-00004)。结果抗结核治疗减轻了各组小鼠的炎症和结核性肺损伤,即使在感染毒性最强的菌株北京396的小鼠中也是如此。在两个时间点观察到所有组的抗结核治疗的显著效果。在毒力最小的菌株Beijing 6691和LAM 7074感染的小鼠中观察到最高的治疗效果。与此同时,在4组治疗小鼠中有3组(感染低毒力菌株LAM 7074的小鼠除外),在5.5个月的治疗过程结束时,细菌负荷略有增加。高覆盖率WGS分析显示,治疗5.5个月后,未出现与给药耐药相关的突变。非特异性炎症反应的研究揭示了不同菌株感染小鼠急性炎症的严重程度不同。结论北京396对小鼠肺损伤最大,低毒北京6691和LAM 7074对小鼠肺损伤最小。同时,在感染LAM菌株的小鼠中观察到不同的炎症反应:感染高毒力菌株4542 (SIT266)的小鼠炎症反应最高,感染低毒力菌株7074 (SIT252)的小鼠炎症反应最低。在系统发育上,这些LAM菌株属于基因同质的LAM- rus分支,它们在体内的差异表现值得注意。结论所观察到的菌株之间的一些差异区分了低毒力和高毒力菌株,而与基因型无关。另一方面,具有相同基因型的Beijing或LAM菌株的一些其他特征是共同的,这可能与基因组中根深蒂固的谱系特异性进化变化有关。总的来说,我们的结果强调了不同基因型结核分枝杆菌菌株适应宿主的方式的多样性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Use of murine model to study virulence of epidemically significant Mycobacterium tuberculosis genotypes and to evaluate effectiveness of chemotherapy

Introduction

The clinical manifestations of tuberculosis (TB) in humans represent a complex interaction between the causative agent, Mycobacterium tuberculosis, and the immune response of the human host. Using the murine model, we compared virulence of M. tuberculosis strains of the medically significant genotypes and evaluated the effectiveness of anti-TB therapy and inflammatory response in infected mice.

Methods

The C57BL/6 mice were infected with multidrug-resistant clinical M. tuberculosis strains of Beijing and LAM genotypes. Control groups were not treated and experimental groups received adequate treatment with moxifloxacin, linezolid, bedaquiline and perchlozone. After 2 and 5.5 months of therapy, groups of mice were euthanized and studied for bacterial load, histology, lung pathology, and biochemical markers of liver damage. Whole genome sequencing was performed on all bacterial isolates from the lungs of the treated mice and the obtained fastq files were analyzed using SAM-TB tool and Geneious package. This study was funded by Russian Science Foundation (grant 24-44-00004).

Results

The anti-TB therapy reduced the inflammation and tuberculous lung damage in all groups of mice, even in those infected with the most virulent strain Beijing 396. A significant effect of the anti-TB therapy was observed at both time-point for all groups. The highest effectiveness of the therapy was observed in mice infected with the least virulent strains Beijing 6691 and LAM 7074. At the same time, in 3 out of 4 groups of treated mice (except for those infected with the low-virulent strain LAM 7074), a slight increase in bacterial load was recorded by the end of the 5.5-month course of therapy. High-coverage WGS analysis showed that no mutations associated with resistance to the administered drugs emerged after 5.5 months of treatment. The study of non-specific inflammatory response revealed the differently severe acute inflammation in mice infected with different strains.

Discussion

The highest lung damage was observed in treated mice infected with Beijing 396, the lowest – in mice infected with low-virulent Beijing 6691 and LAM 7074. At the same time, the contrasting inflammatory responses were observed in mice infected with the LAM strains: the highest in those infected by highly-virulent strain 4542 (SIT266), the lowest – in mice infected with low-virulent strain 7074 (SIT252). Phylogenetically, these LAM strains belong to the genetically homogeneous LAM-RUS branch and their contrasting in vivo manifestation is noteworthy.

Conclusions

Some of the observed differences between studied strains distinguish between low-virulent and highly-virulent strains irrespective of the genotype. On the other hand, some other features were common for the strains of the same genotype either Beijing or LAM and might correlate with deeply rooted lineage-specific evolutionary changes in genomes. Overall, our results emphasize the diversity of ways in which M. tuberculosis strains of different genotypes adapt to the host.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
期刊最新文献
Central nervous system sparganosis: An extraordinary case in an adult and a pediatric patient Clinical significance of negative BioFire® pneumonia panel in ICU: Diagnosis, management, and outcomes Efficacy and safety of albuvirtide intensification for low-level viremia in people with HIV-1: A retrospective pilot study Systematic echocardiography in patients with hematological malignancies and Gram-positive bacteremia, is it really needed? A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1